RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Jazz Pharmaceuticals Stock

Jazz Pharmaceuticals Net Income 2024

Jazz Pharmaceuticals Net Income

1.19 B USD

Ticker

JAZZ

ISIN

IE00B4Q5ZN47

WKN

A1JS1K

In 2024, Jazz Pharmaceuticals's profit amounted to 1.19 B USD, a 187.56% increase from the 414.83 M USD profit recorded in the previous year.

The Jazz Pharmaceuticals Net Income history

YEARNET INCOME (undefined USD)
2029e1.36
2028e1.56
2027e1.48
2026e1.41
2025e1.34
2024e1.19
20230.41
2022-0.22
2021-0.33
20200.24
20190.52
20180.45
20170.49
20160.4
20150.33
20140.06
20130.22
20120.29
20110.13
20100.03
2009-0.01
2008-0.18
2007-0.14
2006-0.08
2005-0.09
2004-0.02

Jazz Pharmaceuticals Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Jazz Pharmaceuticals, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Jazz Pharmaceuticals from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Jazz Pharmaceuticals’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Jazz Pharmaceuticals. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Jazz Pharmaceuticals’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Jazz Pharmaceuticals’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Jazz Pharmaceuticals’s growth potential.

Jazz Pharmaceuticals Revenue, EBIT and net profit per share

DateJazz Pharmaceuticals RevenueJazz Pharmaceuticals EBITJazz Pharmaceuticals Net Income
2029e5.31 B undefined0 undefined1.36 B undefined
2028e5.17 B undefined2.25 B undefined1.56 B undefined
2027e4.89 B undefined2.15 B undefined1.48 B undefined
2026e4.67 B undefined2.03 B undefined1.41 B undefined
2025e4.44 B undefined1.94 B undefined1.34 B undefined
2024e4.13 B undefined1.75 B undefined1.19 B undefined
20233.83 B undefined678.38 M undefined414.83 M undefined
20223.66 B undefined108.9 M undefined-224.1 M undefined
20213.09 B undefined399.3 M undefined-329.7 M undefined
20202.36 B undefined514.2 M undefined238.6 M undefined
20192.16 B undefined532.4 M undefined523.4 M undefined
20181.89 B undefined657.7 M undefined447.1 M undefined
20171.62 B undefined528.8 M undefined487.8 M undefined
20161.49 B undefined593.2 M undefined396.8 M undefined
20151.32 B undefined541.4 M undefined329.5 M undefined
20141.17 B undefined236.9 M undefined58.4 M undefined
2013872.4 M undefined341.8 M undefined216.3 M undefined
2012586 M undefined197.8 M undefined288.6 M undefined
2011272.3 M undefined127.8 M undefined125 M undefined
2010173.8 M undefined57.8 M undefined32.8 M undefined
2009128.4 M undefined15.9 M undefined-6.8 M undefined
200867.5 M undefined-140.6 M undefined-184.3 M undefined
200765.3 M undefined-101.2 M undefined-138.8 M undefined
200644.9 M undefined-78.1 M undefined-81.3 M undefined
200521.4 M undefined-57.1 M undefined-85.2 M undefined
20040 undefined-25.4 M undefined-24.8 M undefined

Jazz Pharmaceuticals stock margins

The Jazz Pharmaceuticals margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Jazz Pharmaceuticals. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Jazz Pharmaceuticals.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Jazz Pharmaceuticals's sales revenue. A higher gross margin percentage indicates that the Jazz Pharmaceuticals retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Jazz Pharmaceuticals's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Jazz Pharmaceuticals's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Jazz Pharmaceuticals's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Jazz Pharmaceuticals. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Jazz Pharmaceuticals's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Jazz Pharmaceuticals Margin History

Jazz Pharmaceuticals Gross marginJazz Pharmaceuticals Profit marginJazz Pharmaceuticals EBIT marginJazz Pharmaceuticals Profit margin
2029e88.64 %0 %25.54 %
2028e88.64 %43.61 %30.19 %
2027e88.64 %43.91 %30.26 %
2026e88.64 %43.47 %30.17 %
2025e88.64 %43.61 %30.12 %
2024e88.64 %42.45 %28.87 %
202388.64 %17.69 %10.82 %
202285.23 %2.98 %-6.12 %
202185.76 %12.9 %-10.66 %
202093.7 %21.75 %10.09 %
201994.08 %24.63 %24.21 %
201893.57 %34.78 %23.64 %
201793.19 %32.67 %30.14 %
201692.92 %39.87 %26.67 %
201592.26 %40.87 %24.87 %
201489.99 %20.2 %4.98 %
201388.3 %39.18 %24.79 %
201286.62 %33.75 %49.25 %
201194.86 %46.93 %45.91 %
201092.17 %33.26 %18.87 %
200992.52 %12.38 %-5.3 %
200879.41 %-208.3 %-273.04 %
200786.37 %-154.98 %-212.56 %
200684.41 %-173.94 %-181.07 %
200580.37 %-266.82 %-398.13 %
200488.64 %0 %0 %

Jazz Pharmaceuticals Aktienanalyse

What does Jazz Pharmaceuticals do?

Jazz Pharmaceuticals PLC is a global biopharmaceutical company specializing in treating life-threatening diseases. The company was founded in 2003 in Ireland and now operates in Europe, North America, and other parts of the world. Jazz's business model focuses on offering innovative therapies for diseases that have no cure or unsatisfactory existing treatments. The company has a well-planned pipeline of high-quality products, supported by excellent customer service and innovative marketing strategies. Jazz holds numerous patents for various medications that can be used for different medical purposes. The company offers four different medical specialties: hematology-oncology, narcolepsy, pain medicine, and psychiatric disorders. Its most well-known specialty is hematology-oncology, where Jazz concentrates on developing therapies for hematological cancers such as leukemia, lymphomas, and myeloma. Furthermore, Jazz provides medications for rare diseases such as Gaucher's disease and Fabry disease. In the field of pain medicine, Jazz Pharmaceuticals has developed specific therapies for patients with sleep disorders and pain. The company also offers treatments for depressive disorders and obsessive-compulsive disorders. Another important area for Jazz is the development of medications for patients suffering from narcolepsy, a condition that causes constant fatigue and sudden sleep attacks, significantly impacting daily life for many patients. One of Jazz Pharmaceuticals' most well-known products is Xyrem, which is used to treat narcolepsy. Xyrem is a potent sedative with a high potential for addiction and can only be prescribed by qualified doctors. Another key product from Jazz is Vyxeos, a medication for the treatment of acute myeloid leukemia, an aggressive form of blood cancer typically difficult to treat. Vyxeos is a dual-action medication that can significantly improve the survival chances of leukemia patients. Jazz Pharmaceuticals is a global leader in hematology-oncology and has become a significant player in the market for medical therapies in recent years. The company currently employs over 1,500 employees and is listed on the NASDAQ. Its headquarters are located in Dublin, Ireland. Jazz Pharmaceuticals is dedicated to supporting patients worldwide with high-quality medical products and services. Jazz Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Jazz Pharmaceuticals's Profit Margins

The profit margins of Jazz Pharmaceuticals represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Jazz Pharmaceuticals's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Jazz Pharmaceuticals's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Jazz Pharmaceuticals's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Jazz Pharmaceuticals’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Jazz Pharmaceuticals stock

How much profit has Jazz Pharmaceuticals made this year?

Jazz Pharmaceuticals has made 1.19 B USD this year.

How has the profit developed compared to last year?

The profit has increased by 187.56% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Jazz Pharmaceuticals publish its earnings?

Jazz Pharmaceuticals publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Jazz Pharmaceuticals?

The profits of Jazz Pharmaceuticals are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Jazz Pharmaceuticals?

You can learn more about the earnings of Jazz Pharmaceuticals by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Jazz Pharmaceuticals pay?

Over the past 12 months, Jazz Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Jazz Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Jazz Pharmaceuticals?

The current dividend yield of Jazz Pharmaceuticals is .

When does Jazz Pharmaceuticals pay dividends?

Jazz Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Jazz Pharmaceuticals?

Jazz Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Jazz Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Jazz Pharmaceuticals located?

Jazz Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Jazz Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Jazz Pharmaceuticals from 7/23/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/23/2024.

When did Jazz Pharmaceuticals pay the last dividend?

The last dividend was paid out on 7/23/2024.

What was the dividend of Jazz Pharmaceuticals in the year 2023?

In the year 2023, Jazz Pharmaceuticals distributed 0 USD as dividends.

In which currency does Jazz Pharmaceuticals pay out the dividend?

The dividends of Jazz Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Jazz Pharmaceuticals

Our stock analysis for Jazz Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Jazz Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.